Max Planck Institute for Biology of Ageing

Max Planck Institute for Biology of Ageing

The Max Planck Institute for Biology of Ageing investigates the natural ageing process with the long-term goal to pave the way towards increasing health during ageing in humans.

Recent News about Max Planck Institute for Biology of Ageing

Edit

Supported companies by Max Planck Institute for Biology of Ageing

Edit
DIREVO Biotech AG
ACQUISITION by Bayer Sep 2008